Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment.

Aim: To study the effect of carbon dioxide (CO) therapy on the nitric oxide (NO) pathway by monitoring plasma asymmetric dimethylarginine (ADMA) concentrations.

Patients And Methods: Forty-seven hypertensive patients who underwent transcutaneous CO therapy were enrolled. Thirty healthy individuals were recruited for the control group.